| Q37838114 | A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population. |
| Q37682229 | A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. |
| Q53354670 | Anemia in chronic kidney disease. |
| Q36790975 | Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients |
| Q42370571 | Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions |
| Q37510989 | Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria |
| Q33583025 | Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds |
| Q40796925 | Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver |
| Q48322013 | Evaluation of the safety of iron dextran with parenteral nutrition in the paediatric inpatient setting |
| Q95407019 | Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial |
| Q34255473 | Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy. |
| Q37701899 | Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. |
| Q40646574 | Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration |
| Q47129994 | Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease |
| Q38213232 | Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia. |
| Q37874704 | Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients |
| Q36333126 | The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale |
| Q42350634 | The rise and rise of randomized clinical evidence in Sub-Saharan Africa |